315 related articles for article (PubMed ID: 26775808)
1. Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.
Ji H; Jiang Z; Lu P; Ma L; Li C; Pan H; Fu Z; Qu X; Wang P; Deng J; Yang X; Wang J; Zhu H
Mol Ther; 2016 Mar; 24(3):508-21. PubMed ID: 26775808
[TBL] [Abstract][Full Text] [Related]
2. Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
Saayman SM; Lazar DC; Scott TA; Hart JR; Takahashi M; Burnett JC; Planelles V; Morris KV; Weinberg MS
Mol Ther; 2016 Mar; 24(3):488-98. PubMed ID: 26581162
[TBL] [Abstract][Full Text] [Related]
3. Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.
Wang X; Wang P; Fu Z; Ji H; Qu X; Zeng H; Zhu X; Deng J; Lu P; Zha S; Song Z; Zhu H
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):98-106. PubMed ID: 25403229
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform.
Morita S; Horii T; Kimura M; Hatada I
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106616
[TBL] [Abstract][Full Text] [Related]
5. Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
Klinnert S; Chemnitzer A; Rusert P; Metzner KJ
J Gen Virol; 2022 Jun; 103(6):. PubMed ID: 35671066
[TBL] [Abstract][Full Text] [Related]
6. Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5'-LTR promoter.
Wang P; Qu X; Wang X; Zhu X; Zeng H; Chen H; Zhu H
Gene Ther; 2014 May; 21(5):490-5. PubMed ID: 24622733
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling.
Zhang Y; Arango G; Li F; Xiao X; Putatunda R; Yu J; Yang XF; Wang H; Watson LT; Zhang L; Hu W
BMC Med Genomics; 2018 Sep; 11(1):78. PubMed ID: 30200981
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
Zhang Y; Yin C; Zhang T; Li F; Yang W; Kaminski R; Fagan PR; Putatunda R; Young WB; Khalili K; Hu W
Sci Rep; 2015 Nov; 5():16277. PubMed ID: 26538064
[TBL] [Abstract][Full Text] [Related]
9. Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir.
Sugiokto FG; Li R
mBio; 2024 Jun; ():e0079524. PubMed ID: 38874417
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-mediated Activation of Latent HIV-1 Expression.
Limsirichai P; Gaj T; Schaffer DV
Mol Ther; 2016 Mar; 24(3):499-507. PubMed ID: 26607397
[TBL] [Abstract][Full Text] [Related]
11. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
Olson A; Basukala B; Lee S; Gagne M; Wong WW; Henderson AJ
Viruses; 2020 Oct; 12(10):. PubMed ID: 33053801
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation.
Omachi K; Miner JH
PLoS One; 2022; 17(6):e0270008. PubMed ID: 35763517
[TBL] [Abstract][Full Text] [Related]
13. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
15. Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models.
da Costa LC; Bomfim LM; Dittz UVT; Velozo CA; da Cunha RD; Tanuri A
Retrovirology; 2022 Jun; 19(1):12. PubMed ID: 35733180
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1.
Tyagi M; Iordanskiy S; Ammosova T; Kumari N; Smith K; Breuer D; Ilatovskiy AV; Kont YS; Ivanov A; Üren A; Kovalskyy D; Petukhov M; Kashanchi F; Nekhai S
Retrovirology; 2015 Jul; 12():63. PubMed ID: 26178009
[TBL] [Abstract][Full Text] [Related]
17. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells.
Petazzi P; Torres-Ruiz R; Fidanza A; Roca-Ho H; Gutierrez-Agüera F; Castaño J; Rodriguez-Perales S; Díaz de la Guardia R; López-Millán B; Bigas A; Forrester LM; Bueno C; Menéndez P
Mol Ther Nucleic Acids; 2020 Jun; 20():196-204. PubMed ID: 32171171
[TBL] [Abstract][Full Text] [Related]
18. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
Song MK; Kim YS
Methods Mol Biol; 2024; 2761():81-91. PubMed ID: 38427231
[TBL] [Abstract][Full Text] [Related]
19. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems.
Papikian A; Liu W; Gallego-Bartolomé J; Jacobsen SE
Nat Commun; 2019 Feb; 10(1):729. PubMed ID: 30760722
[TBL] [Abstract][Full Text] [Related]
20. Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
Bialek JK; Dunay GA; Voges M; Schäfer C; Spohn M; Stucka R; Hauber J; Lange UC
PLoS One; 2016; 11(6):e0158294. PubMed ID: 27341108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
